Merrill Goozner
Washington Monthly
Chicago, IL, United States
Contact Merrill
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Merrill:
How to Stop the Drug Companies from Hiking Prices for Covid Vaccines
The drug companies got rich during the pandemic through massive government subsidies. Now, they want to raise the price of lifesaving treatment. Fostering competition could keep costs down. → Read More
The Electricity Is Too Damn High
High prices at corporate-owned EV charging stations could cripple the spread of climate-friendly transportation. We need to help the mom-and-pops compete. → Read More
Amazon's Health Care Ambitions
The colossus plans to acquire One Medical and put itself at the center of high-end health care. → Read More
GOP Hands Big Pharma a Get-Out-of-Jail-Free Card
The Inflation Reduction Act is being hailed for getting tough on drug companies. In fact, they’ll make out just fine. → Read More
The AMA's Little-Known Committee that Sets Physician Service Prices
Talk about “agency capture.” The American Medical Association’s shadowy “RUC” panel tilts Medicare and Medicaid payments in favor of specialties like surgery and away from needed family care. No wonder it keeps its meetings secret. → Read More
Is a Misguided Hospital Building Boom Coming?
A $2 billion expansion of Mass General Brigham in Boston could open the floodgates. → Read More
The Doctor Will Not See You Now
Primary care is a disaster. Consolidation is making it worse. And a revolution is coming. → Read More
That Wildly Expensive New Alzheimer’s Drug Needs Serious Testing
Why Biogen’s medication, aducanumab, should get studied through an important part of the Affordable Care Act, the Patient Centers Outcomes Research Institute. → Read More
The All-Payer Pricing Alternative
Public option proponents face huge political hurdles; there is another way to achieve many of the same goals. → Read More
Biden’s Pivot on Drug Price Controls
The president abandons the long-held view that innovation requires high prices. → Read More
Editorial: An epidemic of financial toxicity
Lobbyists for providers have launched a lobbying blitz and “dark money” advertising campaign to weaken or scuttle bipartisan bills on balance billing in both chambers of Congress. → Read More
Editorial: Healthcare industry must defend science
It’s getting harder and harder to ignore the Trump administration’s daily assaults on truth and science, not to mention the president’s compulsive divisiveness that threatens the safety of tens of millions of Americans. → Read More
Editorial: It's time to do something about gun violence
To begin reversing the gun violence epidemic, we need to ban civilian ownership of assault weapons since their only use is mass murder; expand background checks; and screen gun purchasers for suicidal tendencies and the propensity to inflict harm on others. → Read More
Editorial: Marianne Williamson—mystic or soothsayer?
During two nights of heated debate, Williamson was the only candidate on stage to address what is arguably the most important question facing America when it comes to health. Why are we so sick? → Read More
Editorial: Let Armstrong’s legacy include one giant leap for healthcare
Here’s hoping the shocking revelation of a suburban Cincinnati hospital’s cover-up of the circumstances surrounding Neil Armstrong’s death will add new momentum to the movement for full transparency of medical errors. → Read More
Editorial: Big Pharma nears another big win
If the tussle over the drug industry’s uncontrolled pricing power were a football game, you’d have to say we’re into the fourth quarter and neither Congress nor the administration has scored a point. → Read More
Editorial: The latest attack on Obamacare
The Trump administration’s project to undermine the Affordable Care Act insurance exchanges is now complete, with its latest rule that will allow employers to funnel tax-exempt cash to employees to buy health coverage. → Read More
Editorial: The health dividend from meaningful work
The road to a healthier life begins by ending the slow death caused by chronic economic insecurity. → Read More
Editorial: When downsizing comes to town
Downsizing in healthcare will only intensify from what appear to be unstoppable technological, demographic and economic trends. Policymakers need a clear-eyed view of the underlying dynamics in order to develop an appropriate response. → Read More
Editorial: Surprise! Demand for healthcare is rising at the VA
Something unexpected has happened at the VA in recent years. The number of vets turning to the government-run healthcare system has risen steadily due to more demand for its specialized care. Giving them access to private-sector care hasn’t reversed the trend. → Read More